119 related articles for article (PubMed ID: 2988403)
1. Central angiotensin converting enzyme blockade and salt preference in renovascular hypertensive rats.
Chan JY; Hutchinson JS
Ann Acad Med Singap; 1985 Jan; 14(1):137-42. PubMed ID: 2988403
[TBL] [Abstract][Full Text] [Related]
2. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
Wu JN; Tsai SY; Hsieh WY
Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
[TBL] [Abstract][Full Text] [Related]
3. Failure of captopril to lower blood pressure in spontaneously hypertensive rats offered water and saline to drink.
DiNicolantonio R
Clin Exp Pharmacol Physiol; 1983; 10(3):269-72. PubMed ID: 6354531
[TBL] [Abstract][Full Text] [Related]
4. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D
Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638
[TBL] [Abstract][Full Text] [Related]
5. Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat.
Evered MD; Robinson MM
J Physiol; 1984 Mar; 348():573-88. PubMed ID: 6325675
[TBL] [Abstract][Full Text] [Related]
6. Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Kishi K; Ikeda M
Gen Pharmacol; 1993 Jul; 24(4):863-6. PubMed ID: 8224740
[TBL] [Abstract][Full Text] [Related]
7. Brain renin angiotensin system contributes to the salt-induced enhancement of hypertension in SHR.
Takata Y; Yamashita Y; Takishita S; Kimura Y; Fujishima M
Clin Exp Hypertens A; 1986; 8(7):1149-70. PubMed ID: 2876791
[TBL] [Abstract][Full Text] [Related]
8. Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat.
Berecek KH; Okuno T; Nagahama S; Oparil S
Hypertension; 1983; 5(5):689-700. PubMed ID: 6413405
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril.
Okuno T; Nagahama S; Lindheimer MD; Oparil S
Hypertension; 1983; 5(5):653-62. PubMed ID: 6311736
[TBL] [Abstract][Full Text] [Related]
10. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
11. Hypotensive effects of captopril administered centrally in intace conscious spontanously hypertensive rats and peripherally in anephric anaesthetized spontaneously hypertensive rats.
Hutchinson JS; Mendelsohn FA
Clin Exp Pharmacol Physiol; 1980; 7(5):555-8. PubMed ID: 7004682
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated salt appetite of spontaneously hypertensive rats is decreased by central angiotensin-converting enzyme blockade.
DiNicolantonio R; Hutchinson JS; Mendelsohn FA
Nature; 1982 Aug; 298(5877):846-8. PubMed ID: 7050726
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the renin-angiotensin system in captopril-induced sodium appetite in the rat.
Elfont RM; Epstein AN; Fitzsimons JT
J Physiol; 1984 Sep; 354():11-27. PubMed ID: 6090647
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on the development of tolerance to guanethidine.
Rankin GO; Haas GJ
Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
[TBL] [Abstract][Full Text] [Related]
15. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
[TBL] [Abstract][Full Text] [Related]
16. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the dose-response effects of captopril in anesthetized normotensive and renovascular hypertensive rats.
Baranes J; Thiévant P; Le Hegarat M; Delaflotte S; Etienne A; Clostre F; DeFeudis FV
Gen Pharmacol; 1982; 13(5):439-43. PubMed ID: 6757046
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure responses of conscious normotensive and spontaneously hypertensive rats to intracerebroventricular and peripheral administration of captopril.
Hutchinson JS; Mendelsohn FA; Doyle AE
Hypertension; 1980; 2(4):546-50. PubMed ID: 6995295
[TBL] [Abstract][Full Text] [Related]
20. A possible explanation of genetic hypertension in the spontaneously hypertensive rat.
Li P; Jackson EK
Life Sci; 1987 Oct; 41(16):1903-8. PubMed ID: 3309518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
